Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Other financing activities (2020 - 2025)

Alignment Healthcare's Other financing activities history spans 6 years, with the latest figure at $26000.0 for Q2 2025.

  • For Q2 2025, Other financing activities changed N/A year-over-year to $26000.0; the TTM value through Dec 2025 reached $26000.0, up 73.33%, while the annual FY2025 figure was $26000.0, 73.33% up from the prior year.
  • Other financing activities reached $26000.0 in Q2 2025 per ALHC's latest filing, up from -$497000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $25.5 million in Q1 2021 to a low of -$25.5 million in Q2 2021.
  • Average Other financing activities over 5 years is $11272.7, with a median of $26000.0 recorded in 2025.
  • The largest YoY upside for Other financing activities was 748.9% in 2021 against a maximum downside of 748.4% in 2021.
  • A 5-year view of Other financing activities shows it stood at -$25.5 million in 2021, then surged by 100.27% to $68000.0 in 2022, then crashed by 188.24% to -$60000.0 in 2023, then tumbled by 728.33% to -$497000.0 in 2024, then soared by 105.23% to $26000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Other financing activities are $26000.0 (Q2 2025), -$497000.0 (Q4 2024), and $497000.0 (Q3 2024).